Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Sell
40
MOH Quote, Financials, Valuation and Earnings
Last price:
$295.04
Seasonality move
:
10.24%
Day range:
$293.27 - $299.70
52-week range:
$272.69 - $423.92
Dividend yield:
0%
P/E ratio:
14.97x
P/S ratio:
0.44x
P/B ratio:
3.53x
Volume:
1.4M
Avg. volume:
739.3K
1-year change:
-16.18%
Market cap:
$16.9B
Revenue:
$34.1B
EPS (TTM):
$19.69
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $16.8B | $19.4B | $27.8B | $32B | $34.1B | |
| Revenue Growth (YoY) | -10.91% | 15.41% | 42.98% | 15.14% | 6.56% | |
| Cost of Revenues | $14.4B | $16.7B | $24.5B | $28B | $29.7B | |
| Gross Profit | $2.4B | $2.7B | $3.3B | $3.9B | $4.3B | |
| Gross Profit Margin | 14.47% | 13.78% | 11.81% | 12.28% | 12.72% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $1.3B | $1.5B | $2.1B | $2.3B | $2.5B | |
| Other Inc / (Exp) | $15M | -$15M | -$25M | -$208M | -- | |
| Operating Expenses | $1.4B | $1.6B | $2.3B | $2.5B | $2.8B | |
| Operating Income | $1B | $1.1B | $1B | $1.4B | $1.6B | |
| Net Interest Expenses | $87M | $102M | $120M | $110M | $109M | |
| EBT. Incl. Unusual Items | $972M | $961M | $875M | $1.1B | $1.5B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $235M | $288M | $216M | $271M | $373M | |
| Net Income to Company | $737M | $673M | $659M | $792M | $1.1B | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $737M | $673M | $659M | $792M | $1.1B | |
| Basic EPS (Cont. Ops) | $11.85 | $11.40 | $11.40 | $13.72 | $18.91 | |
| Diluted EPS (Cont. Ops) | $11.47 | $11.23 | $11.25 | $13.55 | $18.77 | |
| Weighted Average Basic Share | $62.2M | $59M | $57.8M | $57.8M | $57.7M | |
| Weighted Average Diluted Share | $64.2M | $59.9M | $58.6M | $58.5M | $58.1M | |
| EBITDA | $1.1B | $1.2B | $1.1B | $1.3B | $1.7B | |
| EBIT | $1.1B | $1.1B | $995M | $1.2B | $1.6B | |
| Revenue (Reported) | $16.8B | $19.4B | $27.8B | $32B | $34.1B | |
| Operating Income (Reported) | $1B | $1.1B | $1B | $1.4B | $1.6B | |
| Operating Income (Adjusted) | $1.1B | $1.1B | $995M | $1.2B | $1.6B | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $5B | $7B | $7.9B | $8.5B | $10.3B | |
| Revenue Growth (YoY) | 18.34% | 40.21% | 12.6% | 7.83% | 20.96% | |
| Cost of Revenues | $4.3B | $6.3B | $7B | $7.5B | $9.2B | |
| Gross Profit | $683M | $787M | $956M | $1.1B | $1.2B | |
| Gross Profit Margin | 13.6% | 11.18% | 12.06% | 12.47% | 11.5% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $368M | $532M | $560M | $608M | $676M | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $394M | $566M | $621M | $707M | $722M | |
| Operating Income | $289M | $221M | $335M | $359M | $467M | |
| Net Interest Expenses | $27M | $30M | $28M | $27M | $29M | |
| EBT. Incl. Unusual Items | $262M | $191M | $307M | $332M | $438M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $77M | $48M | $77M | $87M | $112M | |
| Net Income to Company | $185M | $143M | $230M | $245M | $326M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $185M | $143M | $230M | $245M | $326M | |
| Basic EPS (Cont. Ops) | $3.14 | $2.49 | $4.00 | $4.24 | $5.67 | |
| Diluted EPS (Cont. Ops) | $3.10 | $2.46 | $3.95 | $4.21 | $5.65 | |
| Weighted Average Basic Share | $58.7M | $57.8M | $57.6M | $57.8M | $57.6M | |
| Weighted Average Diluted Share | $59.6M | $57.8M | $58.3M | $58.1M | $57.7M | |
| EBITDA | $312M | $253M | $380M | $401M | $514M | |
| EBIT | $289M | $221M | $335M | $359M | $467M | |
| Revenue (Reported) | $5B | $7B | $7.9B | $8.5B | $10.3B | |
| Operating Income (Reported) | $289M | $221M | $335M | $359M | $467M | |
| Operating Income (Adjusted) | $289M | $221M | $335M | $359M | $467M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $18.5B | $25.6B | $31.2B | $33.2B | $39.2B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $15.8B | $22.6B | $27.4B | $29B | $34.5B | |
| Gross Profit | $2.7B | $3B | $3.8B | $4.3B | $4.7B | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $1.4B | $1.9B | $2.3B | $2.4B | $2.7B | |
| Other Inc / (Exp) | -$5M | -$10M | -- | -- | -- | |
| Operating Expenses | $1.5B | $2.1B | $2.5B | $2.7B | $3B | |
| Operating Income | $1.2B | $920M | $1.3B | $1.6B | $1.6B | |
| Net Interest Expenses | $92M | $120M | $113M | $109M | $111M | |
| EBT. Incl. Unusual Items | $1.1B | $790M | $1.1B | $1.3B | $1.5B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $325M | $200M | $282M | $322M | $388M | |
| Net Income to Company | $807M | $590M | $839M | $931M | $1.1B | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $807M | $590M | $839M | $931M | $1.1B | |
| Basic EPS (Cont. Ops) | $13.52 | $10.21 | $14.52 | $16.16 | $19.77 | |
| Diluted EPS (Cont. Ops) | $13.34 | $10.07 | $14.33 | $16.04 | $19.69 | |
| Weighted Average Basic Share | -- | -- | -- | -- | -- | |
| Weighted Average Diluted Share | -- | -- | -- | -- | -- | |
| EBITDA | $1.3B | $1B | $1.4B | $1.5B | $1.8B | |
| EBIT | $1.2B | $910M | $1.2B | $1.4B | $1.6B | |
| Revenue (Reported) | $18.5B | $25.6B | $31.2B | $33.2B | $39.2B | |
| Operating Income (Reported) | $1.2B | $920M | $1.3B | $1.6B | $1.6B | |
| Operating Income (Adjusted) | $1.2B | $910M | $1.2B | $1.4B | $1.6B | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $14.2B | $20.4B | $23.8B | $25B | $30.2B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $12.1B | $17.9B | $20.8B | $21.7B | $26.5B | |
| Gross Profit | $2.1B | $2.4B | $2.9B | $3.3B | $3.6B | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $1B | $1.5B | $1.7B | $1.8B | $2.1B | |
| Other Inc / (Exp) | -$5M | -- | -- | -- | -- | |
| Operating Expenses | $1.1B | $1.6B | $1.9B | $2B | $2.3B | |
| Operating Income | $987M | $829M | $1.1B | $1.3B | $1.3B | |
| Net Interest Expenses | $72M | $90M | $83M | $82M | $84M | |
| EBT. Incl. Unusual Items | $910M | $739M | $985M | $1.2B | $1.2B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $271M | $183M | $249M | $300M | $315M | |
| Net Income to Company | $639M | $556M | $736M | $875M | $928M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $639M | $556M | $736M | $875M | $928M | |
| Basic EPS (Cont. Ops) | $10.81 | $9.64 | $12.74 | $15.19 | $16.06 | |
| Diluted EPS (Cont. Ops) | $10.67 | $9.51 | $12.59 | $15.08 | $15.99 | |
| Weighted Average Basic Share | $177.5M | $173.2M | $173.4M | $173M | $173.6M | |
| Weighted Average Diluted Share | $180M | $174.8M | $175.4M | $174M | $174.2M | |
| EBITDA | $1B | $925M | $1.2B | $1.4B | $1.5B | |
| EBIT | $982M | $829M | $1.1B | $1.3B | $1.3B | |
| Revenue (Reported) | $14.2B | $20.4B | $23.8B | $25B | $30.2B | |
| Operating Income (Reported) | $987M | $829M | $1.1B | $1.3B | $1.3B | |
| Operating Income (Adjusted) | $982M | $829M | $1.1B | $1.3B | $1.3B | |
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $2.5B | $4.2B | $4.4B | $4B | $4.8B | |
| Short Term Investments | $1.9B | $1.9B | $3.2B | $3.5B | $4.3B | |
| Accounts Receivable, Net | $1.2B | $1.4B | $1.8B | $2B | $2.7B | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $163M | $175M | $247M | $277M | $331M | |
| Total Current Assets | $6B | $7.9B | $10.1B | $10.1B | $12.5B | |
| Property Plant And Equipment | $385M | $391M | $396M | $259M | $270M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | $143M | $692M | $982M | $1.1B | $1.2B | |
| Other Intangibles | $29M | $249M | $270M | $275M | $208M | |
| Other Long-Term Assets | $184M | $255M | $391M | $361M | $404M | |
| Total Assets | $6.8B | $9.5B | $12.2B | $12.3B | $14.9B | |
| Accounts Payable | $502M | $641M | $842M | $889M | $1.3B | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $3.3B | $5B | $7B | $6.9B | $8.2B | |
| Long-Term Debt | $1.2B | $2.1B | $2.2B | $2.2B | $2.2B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $4.8B | $7.4B | $9.6B | $9.4B | $10.7B | |
| Common Stock | -- | -- | -- | -- | -- | |
| Other Common Equity Adj | $4M | $37M | -$5M | -$160M | -$82M | |
| Common Equity | $2B | $2.1B | $2.6B | $3B | $4.2B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $2B | $2.1B | $2.6B | $3B | $4.2B | |
| Total Liabilities and Equity | $6.8B | $9.5B | $12.2B | $12.3B | $14.9B | |
| Cash and Short Terms | $4.4B | $6B | $7.6B | $7.5B | $9.1B | |
| Total Debt | $1.2B | $2.1B | $2.2B | $2.2B | $2.2B | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $3.2B | $4.4B | $4.2B | $5.6B | $4.7B | |
| Short Term Investments | $1.8B | $2.9B | $3.6B | $4.1B | $4.5B | |
| Accounts Receivable, Net | $1.8B | $1.6B | $1.8B | $2.1B | $2.5B | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $213M | $197M | $391M | $332M | $408M | |
| Total Current Assets | $7B | $9.4B | $10.5B | $12.5B | $12.9B | |
| Property Plant And Equipment | $395M | $385M | $412M | $290M | $306M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | -- | $701M | -- | -- | -- | |
| Other Intangibles | -- | $214M | -- | -- | -- | |
| Other Long-Term Assets | $194M | $284M | $428M | $386M | $421M | |
| Total Assets | $7.9B | $11B | $12.8B | $14.9B | $15.8B | |
| Accounts Payable | $566M | $797M | $818M | $1.1B | $1.2B | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $3.6B | $6.1B | $7.2B | $8.5B | $8.3B | |
| Long-Term Debt | $1.8B | $2.1B | $2.2B | $2.2B | $2.3B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $5.7B | $8.5B | $9.8B | $11B | $11B | |
| Common Stock | -- | -- | -- | -- | -- | |
| Other Common Equity Adj | $37M | $17M | -$185M | -$165M | -$9M | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $2.2B | $2.5B | $3B | $3.9B | $4.8B | |
| Total Liabilities and Equity | $7.9B | $11B | $12.8B | $14.9B | $15.8B | |
| Cash and Short Terms | $5B | $7.3B | $7.9B | $9.7B | $9.2B | |
| Total Debt | $1.8B | $2.1B | $2.2B | $2.2B | $2.3B | |
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $737M | $673M | $659M | $792M | $1.1B | |
| Depreciation & Amoritzation | $89M | $88M | $131M | $176M | $171M | |
| Stock-Based Compensation | $39M | $57M | $72M | $103M | $115M | |
| Change in Accounts Receivable | -$76M | -$100M | -$415M | -$95M | -$778M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $434M | $1.9B | $2.1B | $773M | $1.7B | |
| Capital Expenditures | $57M | $74M | $77M | $91M | $84M | |
| Cash Acquisitions | -- | -$755M | -$129M | -$134M | -$3M | |
| Cash From Investing | -$293M | -$400M | -$1.7B | -$790M | -$744M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $220M | $1.8B | $740M | -- | -- | |
| Long-Term Debt Repaid | -$240M | -$950M | -$723M | -- | -- | |
| Repurchase of Common Stock | -$47M | -$606M | -$128M | -$400M | -- | |
| Other Financing Activities | $22M | -$6M | -$72M | -$41M | -$58M | |
| Cash From Financing | -$559M | $217M | -$183M | -$441M | -$58M | |
| Beginning Cash (CF) | $2.9B | $2.5B | $4.2B | $4.5B | $4B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$418M | $1.7B | $283M | -$458M | $860M | |
| Ending Cash (CF) | $2.5B | $4.2B | $4.5B | $4B | $4.9B | |
| Levered Free Cash Flow | $377M | $1.8B | $2B | $682M | $1.6B | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $185M | $143M | $230M | $245M | $326M | |
| Depreciation & Amoritzation | $23M | $32M | $45M | $42M | $47M | |
| Stock-Based Compensation | $15M | $14M | $23M | $33M | $30M | |
| Change in Accounts Receivable | -$195M | -$55M | $28M | -$49M | -$26M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$158M | $461M | $254M | $949M | $873M | |
| Capital Expenditures | $19M | $27M | $31M | $26M | $35M | |
| Cash Acquisitions | -$62M | -- | -$134M | -$3M | -$49M | |
| Cash From Investing | $60M | -$698M | -$347M | -$280M | -$48M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | $300M | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -$150M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -$500M | |
| Other Financing Activities | -$2M | -$4M | $10M | -$6M | -$14M | |
| Cash From Financing | -$2M | -$4M | $10M | -$6M | -$364M | |
| Beginning Cash (CF) | $3.4B | $4.7B | $4.4B | $5B | $4.4B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$100M | -$241M | -$83M | $663M | $461M | |
| Ending Cash (CF) | $3.3B | $4.4B | $4.3B | $5.6B | $4.9B | |
| Levered Free Cash Flow | -$177M | $434M | $223M | $923M | $838M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $807M | $590M | $839M | $931M | $1.1B | |
| Depreciation & Amoritzation | $85M | $120M | $164M | $175M | $181M | |
| Stock-Based Compensation | $53M | $63M | $103M | $111M | $125M | |
| Change in Accounts Receivable | -$495M | $22M | -$183M | -$212M | -$677M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $635M | $2.8B | $1.6B | $2.1B | $178M | |
| Capital Expenditures | $91M | $66M | $102M | $99M | $84M | |
| Cash Acquisitions | -$62M | -$693M | -$263M | -$3M | -$344M | |
| Cash From Investing | -$115M | -$1.6B | -$1.5B | -$571M | -$508M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $1.2B | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -$500M | -$281M | -- | -- | -- | |
| Other Financing Activities | -$57M | -$27M | -$54M | -$44M | -$61M | |
| Cash From Financing | $12M | -$48M | -$237M | -$244M | -$411M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $532M | $1.2B | -$140M | $1.3B | -$741M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $544M | $2.8B | $1.5B | $2B | $94M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $639M | $556M | $736M | $875M | $928M | |
| Depreciation & Amoritzation | $64M | $96M | $129M | $128M | $138M | |
| Stock-Based Compensation | $43M | $49M | $80M | $88M | $98M | |
| Change in Accounts Receivable | -$369M | -$247M | -$15M | -$132M | -$31M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $599M | $1.5B | $985M | $2.4B | $868M | |
| Capital Expenditures | $64M | $56M | $81M | $89M | $89M | |
| Cash Acquisitions | -$62M | -- | -$134M | -$3M | -$344M | |
| Cash From Investing | $98M | -$1.1B | -$938M | -$719M | -$483M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $1.2B | -- | -- | -- | $300M | |
| Long-Term Debt Repaid | -$600M | -- | -- | -- | -$150M | |
| Repurchase of Common Stock | -$453M | -$128M | -$200M | -- | -$500M | |
| Other Financing Activities | -$55M | -$76M | -$58M | -$61M | -$64M | |
| Cash From Financing | $61M | -$204M | -$258M | -$61M | -$414M | |
| Beginning Cash (CF) | $8.3B | $13.4B | $13.8B | $13.6B | $13.9B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $758M | $212M | -$211M | $1.6B | -$29M | |
| Ending Cash (CF) | $9.1B | $13.6B | $13.5B | $15.2B | $13.9B | |
| Levered Free Cash Flow | $535M | $1.5B | $904M | $2.3B | $779M | |
Get MOH Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
MOH
Sector
P/E ratio
14.97x
25.86x
PEG ratio
0.66x
0.00x
P/B ratio
3.53x
1.85x
Price / LTM sales
0.44x
1.86x
Growth Metrics
MOH
Sector
Revenue growth
20.96%
7.28%
Earnings growth
34.2%
1.82%
Revenue (5-year growth)
12.52%
8.73%
Earnings forecast
$5.94
-$0.20
Profitability
MOH
Sector
Profitability FY 2023
$4.3B
$57.1M
Return on invested capital
17.2%
-14.06%
Return on assets
7.51%
-11.77%
Return on equity
25.77%
-14.78%
Earnings Date
Last Earnings Date
Oct
23
Next Earnings Date
Feb
7
Estimated Next Earnings Date
Jan
22
Balance Sheet
MOH
Sector
Total cash
$9.2B
$47M
Short term investments
$4.3B
$45.2M
Total assets
$14.9B
$142.6M
Long term debt
$2.3B
$6.5M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 21
Quantum [QMCO] is up 26.28% over the past day.
Sell
46
NUKK alert for Dec 21
Nukkleus [NUKK] is down 22.94% over the past day.
Sell
1
IIPR alert for Dec 21
Innovative Industrial Properties [IIPR] is down 22.7% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
